<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39314807</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2772-431X</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Infectious medicine</Title><ISOAbbreviation>Infect Med (Beijing)</ISOAbbreviation></Journal><ArticleTitle>Global research landscape of health care-associated infections among immunocompromised people before and after the start of the COVID-19 pandemic.</ArticleTitle><Pagination><StartPage>100127</StartPage><MedlinePgn>100127</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100127</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.imj.2024.100127</ELocationID><Abstract><AbstractText>Health care-associated infections (HCAIs) pose a substantial threat to immunocompromised individuals and represent a frequent adverse event in health care delivery. The aim of this study was to evaluate the global research landscape of HCAIs among immunocompromised populations before and during the COVID-19 pandemic. A systematic search of articles published between 2013 and 2022 in the Web of Science Core Collection database was conducted, and content analytics and integrated science mapping were used for data analysis and interpretation. The review identified 1,473 articles. Only 633 articles authored by 4,151 individuals and published in 366 journals were included. The average citation rate was 14.27 per document, and research production grew annually by 9.07% peaking in 2021 during the COVID-19 pandemic but declining in 2022. The United States emerged as the most productive country, with 743 publication appearances and 2,485 citations. Keywords such as "epidemiology," "infection," "mortality," and "risk factors" were frequently encountered in the analyzed literature. The main research themes, including "mortality," "sepsis," "immunosuppression," "expression," and "pneumonia," underscored the focal points of importance within this domain. This study highlighted the growing interest regarding HCAIs in immunocompromised populations, especially during the COVID-19 pandemic. The study findings underscore the need to advance research efforts to understand different immunocompromised states, develop tailored infection prevention measures, and address health care disparities to mitigate the burden of HCAIs among immunocompromised individuals.</AbstractText><CopyrightInformation>© 2024 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Iwu</LastName><ForeName>Chidozie Declan</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>School of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria, Pretoria 0001, South Africa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Infect Med (Beijing)</MedlineTA><NlmUniqueID>9918663679306676</NlmUniqueID><ISSNLinking>2772-431X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Health care-associated infections</Keyword><Keyword MajorTopicYN="N">Immunocompromised individuals</Keyword><Keyword MajorTopicYN="N">Patient outcomes</Keyword><Keyword MajorTopicYN="N">Prevention strategies</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>10</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>4</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39314807</ArticleId><ArticleId IdType="pmc">PMC11417551</ArticleId><ArticleId IdType="doi">10.1016/j.imj.2024.100127</ArticleId><ArticleId IdType="pii">S2772-431X(24)00041-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>K.E. Arnold, L. Aver, R. Bennett, et al. National and state healthcare-associated infections progress report 2014. https://stacks.cdc.gov/view/cdc/22160 (accessed July 4, 2023).</Citation></Reference><Reference><Citation>Grohskopf L.A., Sinkowitz-Cochran R.L., Garrett D.O., et al. A national point-prevalence survey of pediatric intensive care unit-acquired infections in the United States. J. Pediatr. 2002;140(4):432–438. doi: 10.1067/mpd.2002.122499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mpd.2002.122499</ArticleId><ArticleId IdType="pubmed">12006957</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization W.H. Libr. Cataloguing Publ. Data; 2011. Report on the Burden of Endemic Health Care-Associated Infection Worldwide; pp. 1–40.</Citation></Reference><Reference><Citation>Magill S.S., Edwards J.R., Bamberg W., et al. Multistate point-prevalence survey of health care-associated infections. N. Engl. J. Med. 2014;370(13):1198–1208. doi: 10.1056/nejmoa1306801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa1306801</ArticleId><ArticleId IdType="pmc">PMC4648343</ArticleId><ArticleId IdType="pubmed">24670166</ArticleId></ArticleIdList></Reference><Reference><Citation>Blot K., Hammami N., Blot S., et al. Seasonal variation of hospital-acquired bloodstream infections: a national cohort study. Infect. Control Hosp. Epidemiol. 2022;43(2):205–211. doi: 10.1017/ice.2021.85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ice.2021.85</ArticleId><ArticleId IdType="pubmed">33975668</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel J.D., Rhinehart E., Jackson M., et al. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am. J. Infect. Contr. 2007;35(10 suppl 2):S65–164. doi: 10.1016/j.ajic.2007.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajic.2007.10.007</ArticleId><ArticleId IdType="pmc">PMC7119119</ArticleId><ArticleId IdType="pubmed">18068815</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Bij A.K., Pitout J.D. The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae. J. Antimicrob. Chemother. 2012;67(9):2090–2100. doi: 10.1093/jac/dks214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dks214</ArticleId><ArticleId IdType="pubmed">22678728</ArticleId></ArticleIdList></Reference><Reference><Citation>Haque M., Sartelli M., McKimm J., et al. Health care-associated infections - an overview. Infect. Drug Resist. 2018;11:2321–2333. doi: 10.2147/IDR.S177247.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S177247</ArticleId><ArticleId IdType="pmc">PMC6245375</ArticleId><ArticleId IdType="pubmed">30532565</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohn A.H., Garrett D.O., Sinkowitz-Cochran R.L., et al. Prevalence of nosocomial infections in neonatal intensive care unit patients: results from the first national point-prevalence survey. J. Pediatr. 2001;139(6):821–827. doi: 10.1067/mpd.2001.119442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mpd.2001.119442</ArticleId><ArticleId IdType="pubmed">11743507</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckardt P., Guran R., Hennemyre J., et al. Hospital affiliated long term care facility COVID-19 containment strategy by using prevalence testing and infection control best practices. Am. J. Infect. Control. 2020;48(12):1552–1555. doi: 10.1016/j.ajic.2020.06.215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajic.2020.06.215</ArticleId><ArticleId IdType="pmc">PMC7332435</ArticleId><ArticleId IdType="pubmed">32622836</ArticleId></ArticleIdList></Reference><Reference><Citation>Micek S.T., Kollef K.E., Reichley R.M., et al. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob. Agents Chemother. 2007;51(10):3568–3573. doi: 10.1128/AAC.00851-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00851-07</ArticleId><ArticleId IdType="pmc">PMC2043297</ArticleId><ArticleId IdType="pubmed">17682100</ArticleId></ArticleIdList></Reference><Reference><Citation>Aria M., Cuccurullo C. Bibliometrix: an R-tool for comprehensive science mapping analysis. J. Informetr. 2017;11(4):959–975. doi: 10.1016/j.joi.2017.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joi.2017.08.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Ejaz H., Zeeshan H.M., Iqbal A., et al. Rubella virus infections: a bibliometric analysis of the scientific literature from 2000 to 2021. Healthc. Basel. 2022;10(12):2562. doi: 10.3390/healthcare10122562.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare10122562</ArticleId><ArticleId IdType="pmc">PMC9778829</ArticleId><ArticleId IdType="pubmed">36554085</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Lei T., Qin Y. An overview of probabilistic preference decision-making based on bibliometric analysis. Appl. Intell. 2022;52(13):15368–15386. doi: 10.1007/s10489-022-03189-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10489-022-03189-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma N., Bairwa M., Gowthamghosh B., et al. A bibliometric analysis of the published road traffic injuries research in India, post-1990. Health Res. Policy Syst. 2018;16(1):18. doi: 10.1186/s12961-018-0298-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12961-018-0298-9</ArticleId><ArticleId IdType="pmc">PMC5831206</ArticleId><ArticleId IdType="pubmed">29490646</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadvand A., Kavanagh D., Clark M., et al. Trends and visibility of “digital health” as a keyword in articles by JMIR publications in the new millennium: bibliographic-bibliometric analysis. J. Med. Internet Res. 2019;21(12):e10477. doi: 10.2196/10477.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/10477</ArticleId><ArticleId IdType="pmc">PMC6940860</ArticleId><ArticleId IdType="pubmed">31855190</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsay M.Y., Yang Y.H. Bibliometric analysis of the literature of randomized controlled trials. J. Med. Libr. Assoc. 2005;93(4):450–458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1250321</ArticleId><ArticleId IdType="pubmed">16239941</ArticleId></ArticleIdList></Reference><Reference><Citation>Cahyadin A.W.Maula, Fuad A. Healthcare-associated infections (HAI) research in Asian countries: a bibliometric analysis. J. Thee Med. Sci. Berkala Ilmu Kedokteran. 2018;50:1–12. doi: 10.19106/jmedsciesup005001201801.</Citation><ArticleIdList><ArticleId IdType="doi">10.19106/jmedsciesup005001201801</ArticleId></ArticleIdList></Reference><Reference><Citation>Advani S.D., Sickbert-Bennett E., Moehring R., et al. The disproportionate impact of coronavirus disease 2019 (COVID-19) pandemic on healthcare-associated infections in community hospitals: need for expanding the infectious disease workforce. Clin. Infect. Dis. 2023;76(3):e34–e41. doi: 10.1093/cid/ciac684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac684</ArticleId><ArticleId IdType="pmc">PMC9452131</ArticleId><ArticleId IdType="pubmed">35997795</ArticleId></ArticleIdList></Reference><Reference><Citation>Macharia P.M., Joseph N.K., Okiro E.A. A vulnerability index for COVID-19: spatial analysis at the subnational level in Kenya. BMJ Glob. Health. 2020;5(8) doi: 10.1136/bmjgh-2020-003014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2020-003014</ArticleId><ArticleId IdType="pmc">PMC7447114</ArticleId><ArticleId IdType="pubmed">32839197</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwu C.D., Ekundayo T.C., Okoh A.I. A systematic analysis of research on Arcobacter: public health implications from a food-environment interphase perspective. Foods. 2021;10(7):1673. doi: 10.3390/foods10071673.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/foods10071673</ArticleId><ArticleId IdType="pmc">PMC8303614</ArticleId><ArticleId IdType="pubmed">34359542</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwu C.D., Patrick S.M. An insight into the implementation of the global action plan on antimicrobial resistance in the WHO African Region: a roadmap for action. Int. J. Antimicrob. Agents. 2021;58(4) doi: 10.1016/j.ijantimicag.2021.106411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2021.106411</ArticleId><ArticleId IdType="pubmed">34371112</ArticleId></ArticleIdList></Reference><Reference><Citation>Pittet L.F., Posfay-Barbe K.M. Vaccination of immune compromised children-an overview for physicians. Eur. J. Pediatr. 2021;180(7):2035–2047. doi: 10.1007/s00431-021-03997-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-03997-1</ArticleId><ArticleId IdType="pmc">PMC8195953</ArticleId><ArticleId IdType="pubmed">33665677</ArticleId></ArticleIdList></Reference><Reference><Citation>Leston M., Elson W., Ordóñez-Mena J.M., et al. Disparities in COVID-19 mortality amongst the immunosuppressed: a systematic review and meta-analysis for enhanced disease surveillance. J. Infect. 2024;88(3) doi: 10.1016/j.jinf.2024.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2024.01.009</ArticleId><ArticleId IdType="pmc">PMC10943183</ArticleId><ArticleId IdType="pubmed">38302061</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>